Anti-PD-1 Immunotherapy and Radiotherapy for Stage IV Intrahepatic Cholangiocarcinoma: A Case Report

Due to the unsatisfactory robustness of current predictive biomarkers in many cases, application of immunotherapy in advanced cancers with limited treatment options, such as stage IV intrahepatic cholangiocarcinoma (ICC), was quite common. Hence, strategies to enhance the therapeutic effect of immun...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Med (Lausanne)
Autori principali: Liu, Ze-Long, Liu, Xin, Peng, Hong, Peng, Zhen-Wei, Long, Jian-Ting, Tang, Di, Peng, Sui, Bao, Yong, Kuang, Ming
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2020
Soggetti:
Medicine
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7485089/
https://ncbi.nlm.nih.gov/pubmed/32984358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.00368
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi